Clinical Research Division

Areas of Research

The Clinical Research Division’s collaborative programs focus on improving therapies for a number of hematologic malignancies, non-malignant diseases and solid tumor cancers. Our researchers strive to understand the genetic basis for these diseases and to translate that knowledge into new treatment approaches.

Our research extends to eliminating barriers to successful therapies such as acute complications during the transplant process or long-term effects after treatment. The goal is to ensure the translation of ideas into clinical trials that are well-constructed, carefully performed and appropriately analyzed.

[About the image: Meduloblastoma tumor from the cerebellum stained to differentiate subsets of neural cells (red) and MyoD (green).]


Bone Marrow and Stem Cell Transplantation

Preclinical

  • Transplantation Biology
  • Human Immunogenetics

Clinical

  • Autologous Stem Cell Transplantation
  • Allogeneic Stem Cell Transplantation
  • Unrelated Donor Transplantation
  • Cord Blood Transplantation
  • Long-Term Follow-Up after Transplantation
  • Transplantation Complications

Biology and Genomics of Hematologic Malignancies

Complications of Cancer Treatments

  • Gastroenterology
  • Pulmonary
  • Nephrology
  • Infectious Diseases

Early Detection

Gene Therapy of Cancer and Genetic Diseases

Immunotherapy

  • Antibody Research
  • T cell Therapy
  • Vaccines

Microchimerism

Molecular Pharmacology

Pathology

Pediatric Oncology

Solid Tumor Biology and Genomics

  • Cell Cycle and Signaling Pathways
  • Prostate Cancer
  • GI Malignancies
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancers
  • Brain Tumors
  • Sarcoma
  • Melanoma
  • Phase I Trials

Statistics and Biomarkers

Survivorship